High-throughput screening (HTS) assay is a method used in drug discovery and other fields to quickly and efficiently test a large number of compounds or samples for a specific biological activity. HTS assays are typically automated and can screen thousands to millions of compounds in a relatively short amount of time. HTS assays are often used in the early stages of drug discovery to identify potential lead compounds that show promising activity against a target of interest. These assays can be used to screen for a wide range of biological activities, such as enzyme inhibition, receptor binding, or cell-based assays. There are several different types of HTS assays, including biochemical assays, cell-based assays, and phenotypic assays. Biochemical assays measure the activity of a specific enzyme or protein, while cell-based assays use living cells to measure the effect of compounds on cellular processes. Phenotypic assays measure a specific observable phenotype, such as cell growth or morphology. Overall, HTS assays are a powerful tool in drug discovery and other fields, allowing researchers to quickly and efficiently screen large libraries of compounds to identify potential drug candidates.
The global High-throughput Screening (HTS) Assay market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
Publisher' newest research report, the 鈥淗igh-throughput Screening (HTS) Assay Industry Forecast鈥� looks at past sales and reviews total world High-throughput Screening (HTS) Assay sales in 2022, providing a comprehensive analysis by region and market sector of projected High-throughput Screening (HTS) Assay sales for 2023 through 2029. With High-throughput Screening (HTS) Assay sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world High-throughput Screening (HTS) Assay industry.
This Insight Report provides a comprehensive analysis of the global High-throughput Screening (HTS) Assay landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on High-throughput Screening (HTS) Assay portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global High-throughput Screening (HTS) Assay market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for High-throughput Screening (HTS) Assay and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global High-throughput Screening (HTS) Assay.
United States market for High-throughput Screening (HTS) Assay is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for High-throughput Screening (HTS) Assay is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for High-throughput Screening (HTS) Assay is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key High-throughput Screening (HTS) Assay players cover Thermo Fisher Scientific, PerkinElmer, Agilent Technologies, Beckman Coulter, Tecan Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of High-throughput Screening (HTS) Assay market by product type, application, key players and key regions and countries.
Segmentation by Type:
Biochemical Assay
Phenotyping Assay
Binding Assay
Aell-based Assay
Others
Segmentation by Application:
Drug Discovery
Identifying New Drug Targets
Toxicology Research
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Biochemical Assay
Phenotyping Assay
Binding Assay
Aell-based Assay
Others
Segmentation by Application:
Drug Discovery
Identifying New Drug Targets
Toxicology Research
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
PerkinElmer
Agilent Technologies
Beckman Coulter
Tecan Group
Hamilton Company
Bio-Rad Laboratories
BMG LABTECH
Promega Corporation
Danaher
Axxam
Merck Millipore
Aurora Biomed
InvivoGen
Biotek Instruments
BPS Bioscience
Eurofins Discovery
Cayman Chemical
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global High-throughput Screening (HTS) Assay Market Size 2019-2030
2.1.2 High-throughput Screening (HTS) Assay Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for High-throughput Screening (HTS) Assay by Country/Region, 2019, 2023 & 2030
2.2 High-throughput Screening (HTS) Assay Segment by Type
2.2.1 Biochemical Assay
2.2.2 Phenotyping Assay
2.2.3 Binding Assay
2.2.4 Aell-based Assay
2.2.5 Others
2.3 High-throughput Screening (HTS) Assay Market Size by Type
2.3.1 High-throughput Screening (HTS) Assay Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global High-throughput Screening (HTS) Assay Market Size Market Share by Type (2019-2024)
2.4 High-throughput Screening (HTS) Assay Segment by Application
2.4.1 Drug Discovery
2.4.2 Identifying New Drug Targets
2.4.3 Toxicology Research
2.4.4 Others
2.5 High-throughput Screening (HTS) Assay Market Size by Application
2.5.1 High-throughput Screening (HTS) Assay Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global High-throughput Screening (HTS) Assay Market Size Market Share by Application (2019-2024)
3 High-throughput Screening (HTS) Assay Market Size by Player
3.1 High-throughput Screening (HTS) Assay Market Size Market Share by Player
3.1.1 Global High-throughput Screening (HTS) Assay Revenue by Player (2019-2024)
3.1.2 Global High-throughput Screening (HTS) Assay Revenue Market Share by Player (2019-2024)
3.2 Global High-throughput Screening (HTS) Assay Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 High-throughput Screening (HTS) Assay by Region
4.1 High-throughput Screening (HTS) Assay Market Size by Region (2019-2024)
4.2 Global High-throughput Screening (HTS) Assay Annual Revenue by Country/Region (2019-2024)
4.3 Americas High-throughput Screening (HTS) Assay Market Size Growth (2019-2024)
4.4 APAC High-throughput Screening (HTS) Assay Market Size Growth (2019-2024)
4.5 Europe High-throughput Screening (HTS) Assay Market Size Growth (2019-2024)
4.6 Middle East & Africa High-throughput Screening (HTS) Assay Market Size Growth (2019-2024)
5 Americas
5.1 Americas High-throughput Screening (HTS) Assay Market Size by Country (2019-2024)
5.2 Americas High-throughput Screening (HTS) Assay Market Size by Type (2019-2024)
5.3 Americas High-throughput Screening (HTS) Assay Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC High-throughput Screening (HTS) Assay Market Size by Region (2019-2024)
6.2 APAC High-throughput Screening (HTS) Assay Market Size by Type (2019-2024)
6.3 APAC High-throughput Screening (HTS) Assay Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe High-throughput Screening (HTS) Assay Market Size by Country (2019-2024)
7.2 Europe High-throughput Screening (HTS) Assay Market Size by Type (2019-2024)
7.3 Europe High-throughput Screening (HTS) Assay Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa High-throughput Screening (HTS) Assay by Region (2019-2024)
8.2 Middle East & Africa High-throughput Screening (HTS) Assay Market Size by Type (2019-2024)
8.3 Middle East & Africa High-throughput Screening (HTS) Assay Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global High-throughput Screening (HTS) Assay Market Forecast
10.1 Global High-throughput Screening (HTS) Assay Forecast by Region (2025-2030)
10.1.1 Global High-throughput Screening (HTS) Assay Forecast by Region (2025-2030)
10.1.2 Americas High-throughput Screening (HTS) Assay Forecast
10.1.3 APAC High-throughput Screening (HTS) Assay Forecast
10.1.4 Europe High-throughput Screening (HTS) Assay Forecast
10.1.5 Middle East & Africa High-throughput Screening (HTS) Assay Forecast
10.2 Americas High-throughput Screening (HTS) Assay Forecast by Country (2025-2030)
10.2.1 United States Market High-throughput Screening (HTS) Assay Forecast
10.2.2 Canada Market High-throughput Screening (HTS) Assay Forecast
10.2.3 Mexico Market High-throughput Screening (HTS) Assay Forecast
10.2.4 Brazil Market High-throughput Screening (HTS) Assay Forecast
10.3 APAC High-throughput Screening (HTS) Assay Forecast by Region (2025-2030)
10.3.1 China High-throughput Screening (HTS) Assay Market Forecast
10.3.2 Japan Market High-throughput Screening (HTS) Assay Forecast
10.3.3 Korea Market High-throughput Screening (HTS) Assay Forecast
10.3.4 Southeast Asia Market High-throughput Screening (HTS) Assay Forecast
10.3.5 India Market High-throughput Screening (HTS) Assay Forecast
10.3.6 Australia Market High-throughput Screening (HTS) Assay Forecast
10.4 Europe High-throughput Screening (HTS) Assay Forecast by Country (2025-2030)
10.4.1 Germany Market High-throughput Screening (HTS) Assay Forecast
10.4.2 France Market High-throughput Screening (HTS) Assay Forecast
10.4.3 UK Market High-throughput Screening (HTS) Assay Forecast
10.4.4 Italy Market High-throughput Screening (HTS) Assay Forecast
10.4.5 Russia Market High-throughput Screening (HTS) Assay Forecast
10.5 Middle East & Africa High-throughput Screening (HTS) Assay Forecast by Region (2025-2030)
10.5.1 Egypt Market High-throughput Screening (HTS) Assay Forecast
10.5.2 South Africa Market High-throughput Screening (HTS) Assay Forecast
10.5.3 Israel Market High-throughput Screening (HTS) Assay Forecast
10.5.4 Turkey Market High-throughput Screening (HTS) Assay Forecast
10.6 Global High-throughput Screening (HTS) Assay Forecast by Type (2025-2030)
10.7 Global High-throughput Screening (HTS) Assay Forecast by Application (2025-2030)
10.7.1 GCC Countries Market High-throughput Screening (HTS) Assay Forecast
11 Key Players Analysis
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific High-throughput Screening (HTS) Assay Product Offered
11.1.3 Thermo Fisher Scientific High-throughput Screening (HTS) Assay Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 PerkinElmer
11.2.1 PerkinElmer Company Information
11.2.2 PerkinElmer High-throughput Screening (HTS) Assay Product Offered
11.2.3 PerkinElmer High-throughput Screening (HTS) Assay Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 PerkinElmer Main Business Overview
11.2.5 PerkinElmer Latest Developments
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Information
11.3.2 Agilent Technologies High-throughput Screening (HTS) Assay Product Offered
11.3.3 Agilent Technologies High-throughput Screening (HTS) Assay Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Agilent Technologies Main Business Overview
11.3.5 Agilent Technologies Latest Developments
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Information
11.4.2 Beckman Coulter High-throughput Screening (HTS) Assay Product Offered
11.4.3 Beckman Coulter High-throughput Screening (HTS) Assay Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Beckman Coulter Main Business Overview
11.4.5 Beckman Coulter Latest Developments
11.5 Tecan Group
11.5.1 Tecan Group Company Information
11.5.2 Tecan Group High-throughput Screening (HTS) Assay Product Offered
11.5.3 Tecan Group High-throughput Screening (HTS) Assay Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Tecan Group Main Business Overview
11.5.5 Tecan Group Latest Developments
11.6 Hamilton Company
11.6.1 Hamilton Company Company Information
11.6.2 Hamilton Company High-throughput Screening (HTS) Assay Product Offered
11.6.3 Hamilton Company High-throughput Screening (HTS) Assay Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Hamilton Company Main Business Overview
11.6.5 Hamilton Company Latest Developments
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Information
11.7.2 Bio-Rad Laboratories High-throughput Screening (HTS) Assay Product Offered
11.7.3 Bio-Rad Laboratories High-throughput Screening (HTS) Assay Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Bio-Rad Laboratories Main Business Overview
11.7.5 Bio-Rad Laboratories Latest Developments
11.8 BMG LABTECH
11.8.1 BMG LABTECH Company Information
11.8.2 BMG LABTECH High-throughput Screening (HTS) Assay Product Offered
11.8.3 BMG LABTECH High-throughput Screening (HTS) Assay Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 BMG LABTECH Main Business Overview
11.8.5 BMG LABTECH Latest Developments
11.9 Promega Corporation
11.9.1 Promega Corporation Company Information
11.9.2 Promega Corporation High-throughput Screening (HTS) Assay Product Offered
11.9.3 Promega Corporation High-throughput Screening (HTS) Assay Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Promega Corporation Main Business Overview
11.9.5 Promega Corporation Latest Developments
11.10 Danaher
11.10.1 Danaher Company Information
11.10.2 Danaher High-throughput Screening (HTS) Assay Product Offered
11.10.3 Danaher High-throughput Screening (HTS) Assay Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Danaher Main Business Overview
11.10.5 Danaher Latest Developments
11.11 Axxam
11.11.1 Axxam Company Information
11.11.2 Axxam High-throughput Screening (HTS) Assay Product Offered
11.11.3 Axxam High-throughput Screening (HTS) Assay Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Axxam Main Business Overview
11.11.5 Axxam Latest Developments
11.12 Merck Millipore
11.12.1 Merck Millipore Company Information
11.12.2 Merck Millipore High-throughput Screening (HTS) Assay Product Offered
11.12.3 Merck Millipore High-throughput Screening (HTS) Assay Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Merck Millipore Main Business Overview
11.12.5 Merck Millipore Latest Developments
11.13 Aurora Biomed
11.13.1 Aurora Biomed Company Information
11.13.2 Aurora Biomed High-throughput Screening (HTS) Assay Product Offered
11.13.3 Aurora Biomed High-throughput Screening (HTS) Assay Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Aurora Biomed Main Business Overview
11.13.5 Aurora Biomed Latest Developments
11.14 InvivoGen
11.14.1 InvivoGen Company Information
11.14.2 InvivoGen High-throughput Screening (HTS) Assay Product Offered
11.14.3 InvivoGen High-throughput Screening (HTS) Assay Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 InvivoGen Main Business Overview
11.14.5 InvivoGen Latest Developments
11.15 Biotek Instruments
11.15.1 Biotek Instruments Company Information
11.15.2 Biotek Instruments High-throughput Screening (HTS) Assay Product Offered
11.15.3 Biotek Instruments High-throughput Screening (HTS) Assay Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Biotek Instruments Main Business Overview
11.15.5 Biotek Instruments Latest Developments
11.16 BPS Bioscience
11.16.1 BPS Bioscience Company Information
11.16.2 BPS Bioscience High-throughput Screening (HTS) Assay Product Offered
11.16.3 BPS Bioscience High-throughput Screening (HTS) Assay Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 BPS Bioscience Main Business Overview
11.16.5 BPS Bioscience Latest Developments
11.17 Eurofins Discovery
11.17.1 Eurofins Discovery Company Information
11.17.2 Eurofins Discovery High-throughput Screening (HTS) Assay Product Offered
11.17.3 Eurofins Discovery High-throughput Screening (HTS) Assay Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Eurofins Discovery Main Business Overview
11.17.5 Eurofins Discovery Latest Developments
11.18 Cayman Chemical
11.18.1 Cayman Chemical Company Information
11.18.2 Cayman Chemical High-throughput Screening (HTS) Assay Product Offered
11.18.3 Cayman Chemical High-throughput Screening (HTS) Assay Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Cayman Chemical Main Business Overview
11.18.5 Cayman Chemical Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.